Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Breathlessness; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202109131224182770-UGPAH. Safety Report Unique Identifier GB-MHRA-ADR 25931570. A male patient of an unspecified age received the second dose of (BNT162B2, Solution for injection) via an unspecified route of administration on 11Sep2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient previously took (BNT162B2), first dose for COVID-19 Immunization. The patient experienced breathlessness (medically significant) on 12Sep2021. Patient has not had symptoms associated with COVID-19. Patient has not tested positive for COVID-19 since having the vaccine. Patient is not enrolled in clinical trial. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 13Dec2020 Yes - Positive COVID-19 test. The outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166